Advertisement
Organisation › Details
CNDA (China National Drug Administration)
Start | 2018-08-20 existent | |
Group | China (govt) | |
Predecessor | CFDA (Chinese Food and Drug Administration) | |
Industry | pharmaceutical | |
City | n. a. | |
Address record changed: 2018-08-25 | ||
Basic data | Employees | n. a. |
Record changed: 2023-07-10 |
Advertisement
More documents for China (govt)
- [1] Boehringer Ingelheim. (4/9/24). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Receives Approval for Supply of EU and US Markets". Ingelheim & Shanghai....
- [2] ERS Genomics Ltd.. (3/26/24). "Press Release: Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual Property Administration". Dublin....
- [3] Bayer AG. (4/13/22). "Press Release: Bayer Receives Approval for Precision Oncology Treatment Vitrakvi in China [Not intended for U.S. and UK Media]". Berlin....
- [4] Bayer AG. (8/27/20). "Press Release: Bayer Receives Approval for Xofigo in China [Not intended for U.S. and UK Media]". Berlin....
- [5] Merck KGaA. (3/2/20). "Press Release: Erbitux Approved for First-Line Use in China in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) [Not intended for UK-based media]". Darmstadt....
- [6] BlueBee. (10/9/19). "Press Release: BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for its Genomics Data Platform". Rijskwijk....
- [7] Novartis AG. (7/19/19). "Press Release: Novartis Key Multiple Sclerosis Product Gilenya Approved in China". Basel....
- [8] Novartis AG. (4/2/19). "Press Release: Novartis First-in-class Cosentyx Approved in China for Psoriasis Patients". Basel....
- [9] Merck KGaA. (11/6/18). "Press Release: Merck Debuts at First China International Import Expo". Shanghai....
- [10] Roche. (8/20/18). "Press Release: China National Drug Administration Grants Rapid Approval of Roche’s Alecensa (alectinib) as a Treatment for ALK-positive Lung Cancer". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top